MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
miscellaneous service companies in Europe:
Idorsia Ltd
of SWITZERLAND
(2019
sales of 23.82 million Swiss Francs [US$24.33 million]
of which 100%
was Discovering,Developing and Commercializi),
Cellectis SA
of FRANCE
(20.57 million Euros [US$22.19 million]
), and
Molecular Partners AG
which is
based in SWITZERLAND
(20.38 million Swiss Francs [US$20.82 million]
).
Sales Analysis.
MDxHealth S.A. reported sales of 19.56 million Euro (US$21.10 million)
for the
year ending
December of 2019.
This
represents
a
decrease of 18.8%
versus 2018, when the company's sales were 24.10 million Euro.